Multiplex Real-Time PCR Assay Simultaneously Detects and Identifies 9 Parasitic Gastrointestinal Pathogens
By LabMedica International staff writers Posted on 12 May 2023 |
The field of parasitology has seen a growing interest in molecular biology. Molecular tools have been extensively used in disciplines such as bacteriology and virology, but the identification of intestinal parasites has been hampered by technical hurdles. Specifically, working with stool samples can be problematic due to the high presence of inhibitors that can disrupt PCR reactions. A novel multiplex PCR assay that allows for the reliable and efficient detection of numerous parasites in a single testing run marks a significant milestone in the field of parasitology.
Seegene, Inc.’s (Seoul, Korea) Allplex GI-Helminth(I) Assay is the first commercially available multiplex PCR assay for the identification of helminths in human stool samples. The assay makes it possible to simultaneously detect and identify nine gastrointestinal parasitic pathogens using real-time PCR. The Allplex GI-Helminth(I) Assay can detect one protozoan and eight helminths, all of which are highly pathogenic parasites. The assay, based on Seegene’s exclusive MuDT technology, provides multiple Ct values for each pathogen in a single channel using real-time PCR instrumentation.
By enabling the simultaneous detection of full range of common intestinal parasites, the informative assay assists in appropriate treatment and management for co-infection. In addition, accurate test results allow for quick and proper treatment. The assay offers a convenient workflow using Seegene’s automated One platform, along with automated data interpretation and LIS interlocking with Seegene Viewer.
Related Links:
Seegene, Inc.
Latest Molecular Diagnostics News
- Blood Proteins Could Warn of Cancer Seven Years before Diagnosis
- New DNA Origami Technique to Advance Disease Diagnosis
- Ultrasound-Aided Blood Testing Detects Cancer Biomarkers from Cells
- New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results
- New Synthetic Biomarker Technology Differentiates Between Prior Zika and Dengue Infections
- Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes
- RNA-Powered Molecular Test to Help Combat Early-Age Onset Colorectal Cancer
- Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia
- Multi-Omic Noninvasive Urine-Based DNA Test to Improve Bladder Cancer Detection
- First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment
- Urine Test to Revolutionize Lyme Disease Testing
- Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease
- New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk
- Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis
- Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays
- Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans